Suvretta Capital Management, Llc
Source: SEC Form 13F · as of Mar 2026Suvretta Capital Management, Llc holds 19 biotech & pharma companies tracked by BioSniper, totaling $1.62B in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$1.62B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Arcutis Biotherapeutics, Inc. (ARQT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | 12,327,000 | $290.4M |
| MANEVeradermics Incorporated | 4,168,970 | $263.3M |
| PVLAPALVELLA THERAPEUTICS, INC. | 1,153,496 | $143.8M |
| APLSApellis Pharmaceuticals, Inc. | 3,518,471 | $141.5M |
| CAPRCAPRICOR THERAPEUTICS, INC. | 3,818,600 | $116.1M |
| IMTXImmatics N.V. | 11,190,129 | $110.1M |
| RCUSArcus Biosciences, Inc. | 5,030,993 | $108.7M |
| KALVKalVista Pharmaceuticals, Inc. | 4,768,712 | $96.0M |
| BHVNBiohaven Ltd. | 10,286,937 | $87.0M |
| CMPXCompass Therapeutics, Inc. | 14,307,379 | $75.7M |
| KURAKura Oncology, Inc. | 8,575,422 | $69.7M |
| ZURAZura Bio Ltd | 9,067,001 | $53.9M |
| PROKPROKIDNEY CORP. | 12,341,266 | $22.1M |
| WHWKWhitehawk Therapeutics, Inc. | 3,700,000 | $12.8M |
| ABEOABEONA THERAPEUTICS INC. | 2,676,000 | $12.0M |
| IFRXInflaRx N.V. | 7,933,910 | $7.1M |
| KZRKezar Life Sciences, Inc. | 716,759 | $5.3M |
| IONSIONIS PHARMACEUTICALS INC | 10,800 | $811K |
| VRDNViridian Therapeutics, Inc.\DE | 16,700 | $327K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.